When you shop through links on our site, we may earn an affiliate commission. This educational content is not intended to be a substitute for professional advice.
20 Best Books On Biotech (2023 Update)
Are you looking for the Best Books On Biotech? If so, you’ve come to the right place.
Choosing the Best Books On Biotech can be difficult as there are so many considerations, such as Electronic Arts, Elsevier, Games Workshop, LEGO, Lion Brand, Nintendo, Penguin Random House, Amazon.com. We have done a lot of research to find the Top 20 Best Books On Biotech available.
The average cost is $47.25. Sold comparable range in price from a low of $6.79 to a high of $142.99.
Based on the research we did, we think Biotechnology Demystified [Book] is the best overall. Read on for the rest of the great options and our buying guide, where you can find all the information you need to know before making an informed purchase.
20 Best Books On Biotech (18 Sellers)
| Product Image | Product Name | Features | Check Price |
|---|---|---|---|
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
Features:
- Explore essential experimental techniques in biotechnology — the stuff of csi.
- Learn what's involved in cancer and the cell cycle infectious diseases. immunology. genetic disease.
- Find out what the human genome project is, and what it's used for.
Features:
- Binding type: paperback
- Year published: 2010-02-24
- Number of pages: 178
Features:
- Up-to-date text focuses on modern biotechnology with a molecular foundation
- Includes clear, color illustrations of key topics and concept
- Features clearly written without overly technical jargon or complicated examples
Features:
- Vetted benchmarks for key drivers of income, expenses, and valuation.
- Proprietary analyses by pharmagellan's experienced consulting team.
- More than 150 current references from peer-reviewed research, industry white papers, and sec filings.
$19.99
5.0
Features:
- Biotechnology law.
- Patent law- general.
- Biotech invention- meaning & overview.
$18.58
5.0
Features:
- Biotechnology law.
- Patent law- general.
- Biotech invention- meaning & overview.
Features:
- Term "monetisation" of intellectual property.pisano maintains that all industry players.
- Biotech firms, investors, universities, pharmaceutical companies, government regulators.
- Can play a role in righting the industry.
Features:
- Product details
- Publisher: taylor & francis
- Publication date: 09-01-2016
Features:
- Structured roadmap for assessing the main components of a planned or completed biotech trial.
- Clear explanations of the most common concepts and terms in biotech clinical studies, illustrated with over 100 real-world examples.
- Deep dives on essential topics like p values, sample size calculations, and kaplan-meier curves, written in plain english for non-statisticians.
Features:
- Binding type: paperback
- Publisher: the university of chicago press
- Year published: 2013-05-03
Features:
- About the book
- Book synopsis
- About the author
$6.79
Features:
- Binding type: paperback
- Publisher: mcgraw-hill education – europe
- Year published: 2003-04-16
$20.33
Features:
- Binding type: paperback
- Publisher: mcgraw-hill education – europe
- Year published: 2003-04-16
$18.65
Features:
- Tracking the effect of breaking news and the nasdaq
- Anticipating drug trial announcements and fda approvals
- Assessing the potential market, patent rights, and distribution deals for a drug
Features:
- Binding : paperback
- Pages : 216
- Publisher : createspace independent publishing platform
Features:
- Author: michael malinowski, michael malinowski
- Languages: english
- Product format: paperback / softback
Features:
- What is biotechnology? — the raw materials of biotechnology — the basic skills of the biotechnology workplace — introduction to studying dna — introduction to studying proteins — identifying…
Features:
- Mint condition
- Dispatch same day for order received before 12 noon
- Guaranteed packaging
Features:
- Relates basic principles and concepts to practical applications for environmental treatment
- Covers emerging technologies and processes that have emerged in recent years
- Written by a pair of award-winning environmental engineers and experienced educators
Features:
- About the book
- Book synopsis
- About the author
1. Biotechnology Demystified [Book]
Product Details:
Publisher's note: products purchased from third party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. – discover all the red-hot areas of biotechnology! encompassing everything from promising new drug therapies and experimental treatment of genetic disorders to potential pandemics and bioterrorist threats, biotechnology is one of the most talked-about and exciting branches of science. and there is no faster or more effective way to master all the essential subtopics within this emerging area. – biotechnology demystified lets you learn at your own comfortable pace. coverage advances logically and smoothly, from the basics of molecular and cellular biology to more complex topics. in this unique guide, learning is continually reinforced and achievement demonstrated. multiple-choice quizzes at the ends of chapters and a final exam help guide you to topic mastery — without stress or anxiety. – this one-of-a-kind self-teaching text helps you:understand molecules and the cellular basis of life — how information flows within the cell… dna replication and cell division… how cells interact with what's "outside"explore essential experimental techniques in biotechnology — the stuff of "csi"learn what's involved in cancer and the cell cycle… infectious diseases… immunology… genetic disease – find out what the human genome project is, and what it's used for – understand the science and controversy surrounding reproductive cloning and genetically modified (gm) crops – keep up with the accelerating pace of new drug development – take a "final exam" and grade it yourself! simple enough for a beginner, but challenging enough for an advanced student, biotechnology demystified is a lively and entertaining guide to understanding a science that's making the news daily!
Reviews:
I'm going into the Biotechnology program at the University of Nevada (excellent biotech program) and this book (along with several others I purchased) is perfect!! I love the way the information is laid out and it even goes over stuff previously presented in other bio classes i.e. cell structure, molecular bonds, stuff like that. I found the diction to be completely understandable and it actually kind of sucks you in when you really start reading it…completely fascinating! I truly recommend this book for the beginner biotech student…it'll totally prep you before your classes start. 🙂g_o_e
2. The Biotech Trader Handbook: A Fast, Simplified And Efficient Guide To Potentially Generate Outsized Returns In Biotech Using Options (For The Non-Scientist) [Book]
Product Details:
Small cap biotech companies spend hundreds of millions of dollars and over ten years moving experimental drug candidates from concept to fully approved drugs. for late stage drug candidates, those in phase iii, positive or negative data can result in either massive gains or devastating declines in the sponsoring company's stock price. this "ultimate catalyst event" provides smart, organized & nimble option traders spectacular & consistent trading opportunities. in this unique book, the author provides individuals unfamiliar with the world of small cap biotech a fast, simplified and efficient approach to identify, analyze & execute trading strategies using options. the following topics, amongst others, are covered in this book: * description of the fda drug trial process, from pre-clinical to phase iii & beyond * identification, categorization & organization of small cap biotech companies * structured & streamlined approach to assess small cap biotech companies * notes on trading strategy & tactics * detailed description of option trading structures best suited for small cap biotech this book is an absolute "must have" for individuals thinking about trading in the fast paced and often confusing world of small cap biotech.
Specifications:
| Language | English |
| Release Date | February 2010 |
| Length | 178 Pages |
| Dimensions | 0.4" x 6.0" x 9.0" |
3. Biotechnology [Book]
Product Details:
Biotechnology, second edition approaches modern biotechnology from a molecular basis, which has grown out of increasing biochemical understanding of genetics and physiology. using straightforward, less-technical jargon, clark and pazdernik introduce each chapter with basic concepts that develop into more specific and detailed applications. this up-to-date text covers a wide realm of topics including forensics, bioethics, and nanobiotechnology using colorful illustrations and concise applications. in addition, the book integrates recent, relevant primary research articles for each chapter, which are presented on an accompanying website. the articles demonstrate key concepts or applications of the concepts presented in the chapter, which allows the reader to see how the foundational knowledge in this textbook bridges into primary research. this book helps readers understand what molecular biotechnology actually is as a scientific discipline, how research in this area is conducted, and how this technology may impact the future. up-to-date text focuses on modern biotechnology with a molecular foundation includes clear, color illustrations of key topics and concept features clearly written without overly technical jargon or complicated examples provides a comprehensive supplements package with an easy-to-use study guide, full primary research articles that demonstrate how research is conducted, and instructor-only resources
Reviews:
I frankly didn't know what to expect from this textbook. While I'm not affiliated with any institution, I'm an autodidact with interest in genetics and biochemistry. This book gives an excellent, thorough introduction to a very broad swathe of categories. It is not a specialist book, as that is intended by the authors I believe (biotechnology, the text mentions, is a huge multidisciplinary field). What it was good for was bridging my recent microbiology and chemistry exposure and showing me applications in the real world. It also gives a good image of possibilities and current limitations, as well as areas of research that I may potentially pursue. While this was great, I have to deduct some points for the lack of concrete data contained in the textbook. It was clearly written for someone with minimal exposure to technical mathematics or statistics, perhaps for a first year student of biological sciences. That is both a blessing and a curse, as the takeaway from the text itself is a little nebulous. It certainly lacks any tangible biophysics component. Perhaps that was the intent, but it certainly makes me hanker for a little more data driven deliveries.MichaelDueck
4. The Pharmagellan Guide To Biotech Forecasting And Valuation [Book]
Product Details:
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser–or aspire to be one–then you need to know how to build and analyze forecasts and valuation models of r&d-stage drugs. the pharmagellan guide to biotech forecasting and valuation is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies. – vetted benchmarks for key drivers of income, expenses, and valuation. – proprietary analyses by pharmagellan's experienced consulting team. – more than 150 current references from peer-reviewed research, industry white papers, and sec filings. whether you're making investment decisions, pitching to potential partners or funders, or assessing your own r&d program, this is the one-stop guide you need by your side.
5. Biotechnology: A Guide To Scientific Approach And Technological Innovation (A Comprehensive Book On The Biotech Patent Laws Includes Biotechnology Business) [Book]
Product Details:
This book is intended to expose students of life sciences to biotechnology, a vibrant and ever-evolving discipline. you will gain knowledge of methodologies and tools used in this field. read, enjoy and learn as this book walk you through the fundamentals of biotechnology and equips you with many of the necessary skills to excel in this field. in this book, you will: what is biotechnology? biotechnology law – patent law- general – biotech invention- meaning & overview – invention or discovery? factors that may indicate invention – does biotechnology invention need patent protection? the book gives general ideas about biotechnology, describes its main objects, outlines the basics of cellular, tissue and genetic engineering, cryopreservation. the part includes the basics of industrial biotechnology, enzymatic engineering, environmental biotechnology, nanobiotechnology the book will be extremely useful for all students studying biotechnology at graduate or post graduate level.
Reviews:
6. Biotechnology: A Guide To Scientific Approach And Technological Innovation (A Comprehensive Book On The Biotech Patent Laws Includes Biotechnology Business) [Book]
Product Details:
This book is intended to expose students of life sciences to biotechnology, a vibrant and ever-evolving discipline. you will gain knowledge of methodologies and tools used in this field. read, enjoy and learn as this book walk you through the fundamentals of biotechnology and equips you with many of the necessary skills to excel in this field. in this book, you will: what is biotechnology? biotechnology law – patent law- general – biotech invention- meaning & overview – invention or discovery? factors that may indicate invention – does biotechnology invention need patent protection? the book gives general ideas about biotechnology, describes its main objects, outlines the basics of cellular, tissue and genetic engineering, cryopreservation. the part includes the basics of industrial biotechnology, enzymatic engineering, environmental biotechnology, nanobiotechnology the book will be extremely useful for all students studying biotechnology at graduate or post graduate level.
Reviews:
7. Science Business: The Promise, The Reality, And The Future Of Biotech [Book]
Product Details:
Why has the biotechnology industry failed to perform up to expectations–despite all its promise? pisano answers this question by providing an incisive critique of the industry. pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. and he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. according to pisano, the biotech industry's problems stem from its special character as a science-based business. this character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for r&d, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.the key to fixing the industry? business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter–term 'monetisation' of intellectual property. pisano maintains that all industry players–biotech firms, investors, universities, pharmaceutical companies, government regulators–can play a role in righting the industry. the payoff? valuable improvements in health care, and a shinier future for human well-being.
8. Biotechnology Operations: Principles And Practices [Book]
Product Details:
This book describes seven areas in the field of biotechnology operations as practiced by biopharmaceutical firms and nonprofit institutions. revisions focus upon changes that have occurred in several areas over the past six years, with emphasis on regulatory, biomanufacturing, clinical and technical information, along with processes and guidlines that have added to the discipline. examples are increased for new technical fields such as cell and tissue engineering. further, illustrations or figures are added to each chapter to emphasize particular points.
9. The Pharmagellan Guide To Analyzing Biotech Clinical Trials [Book]
Product Details:
A comprehensive primer to help non-experts evaluate clinical studies of new therapies. if you work in or around biotech, you're supposed to understand clinical trial results. but what if you're not an expert in study design or biostatistics? you may feel out of your comfort zone when faced with a journal article, press release, or investor presentation. inside this book: — structured roadmap for assessing the main components of a planned orcompleted biotech trial.– clear explanations of the most common concepts and terms in biotechclinical studies, illustrated with over 100 real-world examples.– deep dives on essential topics like p values, sample size calculations, and – kaplan-meier curves, written in plain english for non-statisticians.– pointers for interpreting positive and negative study results, understandingcommon figures and tables, and identifying red flags in press releases. – if you're a biotech executive, investor, advisor, or entrepreneur–or aspire to be one–this handbook will give you the foundation you need to analyze planned and completed clinical trials with more confidence." hugely helpful. i wish i'd had a book like this earlier in my career." – sir menepangalos, executive vp, biopharmaceuticals r&d, astra – zeneca"a terrific primer for non-experts looking to better evaluate new therapies." -daphne zohar, founder and ceo, pure – tech health"crisp and clear. wise advice on when to rely on clinical data and when to beskeptical." – michael rosenblatt, senior partner, flagship pioneering"a source of much-needed illumination." – dan lepanto, senior managing – director, m&a, svb leerink
10. Genentech: The Beginnings Of Biotech [Book]
Product Details:
In the fall of 1980, genentech, inc., a little-known california genetic engineering company, became the overnight darling of wall street, raising over $38 million in its initial public stock offering. coming at a time of economic recession and declining technological competitiveness in the united states, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. drawing from an unparalleled collection of interviews with early biotech players, sally smith hughes offers the first book-length history of this pioneering company, depicting genentech’s improbable creation, precarious youth, and ascent to immense prosperity. hughes provides intimate portraits of the people significant to genentech’s science and business, including cofounders herbert boyer and robert swanson, and in doing so sheds new light on how personality affects the growth of science. by placing genentech’s founders, followers, opponents, victims, and beneficiaries in context, hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. integrating the scientific, the corporate, the contextual, and the personal, genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.
11. Lords Of The Harvest: Biotech, Big Money, And The Future Of Food [Book]
Product Details:
Biotech companies are creating designer crops with strange powers-from cholesterol-reducing soybeans to tobacco plants that act as solar-powered pharmaceutical factories. they promise great benefits: better health for consumers and more productive agriculture. but the vision has a dark side. in lords of the harvest, daniel charles tells the real story behind "frankenstein foods"-the story you won't hear from the biotech companies or their fiercest opponents. he reveals for the first time the cutthroat scientific competition and backroom business deals that led to the first genetically engineered foods. and he exposes the secrets of campaigns on both sides of the atlantic aimed at bringing down the biotech industry. a riveting tale of boundless ambition, political intrigue, and the quest for knowledge, lords of the harvest is ultimately a story of idealism and conflicting dreams about the shape of a better world.
Reviews:
12. The Biotech Age: The Business Of Biotech And How To Profit From It [Book]
Product Details:
Since the coming biotech age was published in 1999, much has changed in this fast-moving, volatile industry. furthermore, media attention on biotech, especially ethical and legislative issues, has increased several times over. biotech companies are featured regularly in business publications and general interest magazines and newspapers are running stories on cloning and stem cell research on an almost daily basis. major developments that have taken place since the book was published, the human genome was mapped by celera genomics in june, 2000, well ahead of schedule, just a few months after a rough draft was finished. stem cell research has become front-page news, with debates in congress, the white house, and the public forums being hotly contested. the politically powerful "right to life" camp has split down the middle on the issue. funding and investment in biotech have increased at a rapid pace, with the tech meltdown having little effect on the biotech environment. market capitalization increased from usd138 billion when the book was written to over usd330 billion in 2001, despite declines in the overall markets. ; there are now more than 350 biotech drugs and vaccines in clinical trials, targeting more than 200 diseases. total sales and revenues in at biotech companies both increased over 10 percent in the year following the book's publishing, despite the ongoing recession. medical biotech companies have gained much more clout in negotiations with big pharma, especially after raising a record usd31 billion in 2000. in 2001, gm crops comprised 74 percent of all soybeans grown in the us, 71 percent of all cotton, and 32 percent of all corn. in 2000, the us supreme court upheld the rights of companies to patent hybrid and genetically modified plants. all of the above and more – including a new introduction and conclusion – will be covered in this completely revised and updated paperback edition
13. The Biotech Age: The Business Of Biotech And How To Profit From It [Book]
Product Details:
Since the coming biotech age was published in 1999, much has changed in this fast-moving, volatile industry. furthermore, media attention on biotech, especially ethical and legislative issues, has increased several times over. biotech companies are featured regularly in business publications and general interest magazines and newspapers are running stories on cloning and stem cell research on an almost daily basis. major developments that have taken place since the book was published, the human genome was mapped by celera genomics in june, 2000, well ahead of schedule, just a few months after a rough draft was finished. stem cell research has become front-page news, with debates in congress, the white house, and the public forums being hotly contested. the politically powerful "right to life" camp has split down the middle on the issue. funding and investment in biotech have increased at a rapid pace, with the tech meltdown having little effect on the biotech environment. market capitalization increased from usd138 billion when the book was written to over usd330 billion in 2001, despite declines in the overall markets. ; there are now more than 350 biotech drugs and vaccines in clinical trials, targeting more than 200 diseases. total sales and revenues in at biotech companies both increased over 10 percent in the year following the book's publishing, despite the ongoing recession. medical biotech companies have gained much more clout in negotiations with big pharma, especially after raising a record usd31 billion in 2000. in 2001, gm crops comprised 74 percent of all soybeans grown in the us, 71 percent of all cotton, and 32 percent of all corn. in 2000, the us supreme court upheld the rights of companies to patent hybrid and genetically modified plants. all of the above and more – including a new introduction and conclusion – will be covered in this completely revised and updated paperback edition
14. The Biotech Investor: How To Profit From The Coming Boom In Biotechnology [Book]
Product Details:
"tom abate's reporting on biotechnology has always been ahead of the times. the biotech investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." —thom calandra, editor in chief, cbs marketwatchin the biotech investor, san francisco chronicle biotechnology reporter tom abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry. abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. he shares strategies for – tracking the effect of breaking news and the nasdaq – anticipating drug trial announcements and fda approvals – assessing the potential market, patent rights, and distribution deals for a drughe looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. the biotech investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
15. Biotechnology Valuation & Investing: Biotech Valuation & Investing [Book]
Product Details:
Janet yellen, the fed chair, recently said that the valuations of small-cap biotechnology companies are substantially stretched. biotechnology is a relatively new science and during the last few years there is an increasing number of new biotech start-up companies and also m&a activity between biotech start-ups and large biotechnology and pharmaceutical companies. more recently, moderna therapeutics, a biotech company developing mrna therapeutics, broke the record of vc funding, raising $450 million dollars in a single round of funding, without having a product in the market. all these recent events raise an important question: what are the valuation financial models used in the biotechnology industry? is there any difference on valuating a phase ii drug against arthritis vs a phase ii anti-cancer drug? this book is aiming to answer these essential questions by describing the key aspects of the drug discovery process, including novel financial models used for valuation of biotech companies.
Specifications:
| Language | English |
| Release Date | October 2018 |
| Length | 76 Pages |
| Dimensions | 0.2" x 6.1" x 9.2" |
16. Handbook On Biotechnology Law, Business, And Policy: Human Health Products From The Laboratory Bench To Market Approvals [Book]
Product Details:
"this book offers readers access to a baseline of 'critical mass' knowledge in commercial biotech research and development ("r&d"). the clear, concise coverage spans from laboratory bench research to regulatory market approvals for a range of the primary biotech human health products. this book is an invaluable reference resource for law, business, and medical school educators and students; biopharmaceutical executives; investors in the field; university and other research institution professionals, such as technology transfer administrators; research scientists; regulators; and the general public with interest in the enormous economic and human health impact of biotechnology."
Specifications:
| Language | English |
| Release Date | March 2016 |
| Length | 274 Pages |
| Dimensions | 6.3" x 9.3" |
17. Biotechnology: Science For The New Millennium [Book]
Product Details:
What is biotechnology? — the raw materials of biotechnology — the basic skills of the biotechnology workplace — introduction to studying dna — introduction to studying proteins — identifying a potential biotechnology product — spectrophotometers and assays for biotechnology products — the production of a recombinant biotechnology product — bringing a biotechnology product to market — introduction to plant biotechnology — biotechnology in agriculture — biotechnology in medicine — making dna molecules — advanced biotechnology techniques.
Specifications:
| Binding | Hardcover |
| Language | English |
| Publication Year | 2007 |
Reviews:
Product was probably better than expected.jowil-1851
18. Science Lessons: What The Business Of Biotech Taught Me About Management [Book]
Product Details:
Widely regarded as the most innovative, successful biotech firm ever, amgen led its industry in revenue and sales growth in 2007. top magazines including fortune and industry week have repeatedly named it one of america's best companies to work for. in science lessons, gordon binder–ceo and chairman during 1988-2000–describes amgen's climb to success. revealing the highs and lows it experienced in the race to develop blockbuster drugs, he takes readers from the time amgen had just three months of capital in the bank and no viable products in the pipeline to its spectacular success. the turning point? the 1989 launch of epogen, which dramatically helped kidney dialysis patients suffering from debilitating anemia. other landmark drugs, including neupogen, would follow. through engaging anecdotes and cogent insights, binder weaves a fascinating tale while offering his unique brand of practical management advice. using the principals of the scientific method, he shares his recommendations for tackling pressing business challenges–such as managing creative employees, navigating the ipo process, and protecting intellectual property. this colorful first-person account showcases the visionary science and daring business strategy that made amgen great–offering valuable lessons for all companies.
19. Environmental Biotechnology: Principles And Applications, Second Edition [Book]
Product Details:
Publisher's note: products purchased from third party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.the classic environmental biotechnology textbook—fully updated for the latest advancesthis thoroughly revised educational resource presents the biological principles that underlie modern microbiological treatment technologies. written by two of the field’s foremost researchers, environmental biotechnology: principles and applications, second edition, clearly explains the new technologies that have evolved over the past 20 years, including direct anaerobic treatments, membrane-based processes, and granular processes. the first half of the book focuses on theory and tools; the second half offers practical applications that are clearly illustrated through real-world examples.coverage includes: – moving toward sustainability – basics of microbiology – biochemistry, metabolism, genetics, and information flow – microbial ecology – stoichiometry and energetics – microbial kinetics and products – biofilm kinetics – reactor characteristics and kinetics – methanogenesis – aerobic suspended-growth processes – aerobic biofilm processes – nitrogen transformation and recovery – phosphorus removal and recovery – biological treatment of drinking water
20. From Alchemy To Ipo: The Business Of Biotechnology [Book]
Product Details:
"a tour-de-force for anyone who is interested in the biotech industry. i applaud the enormous achievement of cynthia robbins-roth."-frederick frank, senior managing director & vice chair, lehman brothers"from alchemy to ipo tells the dramatic story of this revolutionary industry as only an insider can."-george rathmann, president and ceo, icos corporation, chairman emeritus, amgenwritten by a well-known industry insider, from alchemy to ipo addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. it describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market.
